STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders
Clinical trial NCT00858572 · COMPLETED
Trial details
- NCT number
- NCT00858572
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-05-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.